For 5–20 years, chronic disease builds silently, invisible to standard diagnostics. Kale reads 1,000+ proteins across every system in your body, predicts your health trajectory years early, and delivers personalized clinical care to change it.
Standard diagnostics catch what is already wrong. Kale uses proteomics and machine learning to read what is happening underneath the surface across every system in your body. We measure disease risk and the biological age of each organ from a single blood draw, so intervention can begin earlier and with greater precision.
You book a blood draw. Your sample is analyzed at a CLIA-certified lab, where we read standard blood markers alongside 1,000+ proteins in your plasma — giving us insight into your full multi-system biology.
We translate the signal with ML into projected risk trajectories across multiple systems including cardiovascular, cognitive, metabolic, hormonal, inflammatory axes and more. A trajectory isn't a destination — surfacing risk this early is what makes prevention possible.
A clinician builds your proactive health plan across prescriptions, supplements and lifestyle, coordinated across systems. Intervention focuses on treating you proactively to keep you healthy long-term, based on where we see the most risk.
Every 3–6 months we re-read your biology to see what is actually working in your specific body. Reading plasma proteomics lets us see what's changed on a molecular level and how your long-term risk has evolved. The loop closes. Your plan adapts. Your trajectory measurably changes.
Perimenopause isn't just hot flashes. Declining estrogen puts you at higher risk across cardiovascular, bone, cognitive, and metabolic systems. Kale reads every system at once to help you understand where your risk is highest, then builds an integrated plan to manage it, verified every 3–6 months.
If you carry APOE4, have a parent or grandparent with dementia, or notice subjective changes, you are in the highest-leverage moment for prevention. Kale integrates the six systems driving cognitive risk and tracks the proteomic signals that reflect what is happening in your brain decades before standard cognitive testing can catch it.
Kale is being built as the clinical platform for a full range of preventive health verticals: cardiovascular, hormonal, cognitive, metabolic, sleep, bone, and beyond. Wherever proactive intervention can change a long-horizon trajectory, Kale delivers integrated care across every system.
Pharma is developing a wave of long-horizon preventive drugs: siRNAs for cardiovascular risk, advanced peptides, cognitive preservation therapies, designed to treat asymptomatic, at-risk patients. Kale becomes the platform that delivers them.